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Background
Transforming Growth Factor beta (TGFb)i sah i g h l y
pleiotropic cytokine that is involved in numerous signal-
ling pathways, including immune homeostasis. It is
secreted by all immune cell lineages and is classically
viewed as an anti-inflammatory cytokine. TGFb is asso-
ciated with regulatory T cell (Treg) induction, and Treg-
function. However, in combination with pro-inflamma-
tory cytokines (IL-6, IL-b and IL-23) TGFb will induce
proinflammatory Th17 cells. In several autoimmune dis-
eases, including Juvenile Idiopathic Arthritis (JIA), a dis-
rupted Th17-Treg balance, lower Treg numbers or less
functional Tregs have been described.
Unfortunately TGFb production is hard to measure.
Popular methods like flow cytometry or ELISA are not
reliable, not sensitive or require activation of all latent
TGFb present, which might not be representative.
Aim
To develop a reliable and sensitive test to assess active
TGFb level in serum, and T cell cultures.
Methods
The mink cell line CCL-64 is used to assess TGFb levels
in serum. Cells are cultured in serum free medium for
24hrs before serum is added. After 19hrs incubation
3H-thymidine is added and cell proliferation is assessed
after 5hrs.
Evaluation
The highly sensitive cell line CCL-64 is currently estab-
lished in our lab.The next months serum samples and T
cell cultures of JIA and other autoimmune patients will
be tested.
Conclusion
A sensitive bioassay for active TGFb may provide a bet-
ter understanding of the role of TGFb in Treg number
and function as well as the Th17-Treg balance in auto-
immune diseases.
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